Congratulations, Joe, on your seminal contribution!
Scott Thompson, PhD
CCTSI researcher Joseph Schacht, PhD, is studying how semaglutide (GLP‑1 meds like #Ozempic) could help treat #alcohol use disorder. Findings from his study at our Clinical Translational Research Center show reduced alcohol cravings, consumption, and heavy drinking days. ▶️ buff.ly/oreXkVG
Colorado Clinical and Translational Sciences Institute (CCTSI)
